Prognostic value of metformin for non-small cell lung cancer patients with diabetes
Abstract Background The anti-cancer role of metformin has been reported in many different kinds of solid tumors, but how it affects non-small cell lung cancer (NSCLC) is currently elusive. The aim of this study was to investigate the influence of metformin treatment on diabetic NSCLC. Methods Two hu...
Main Authors: | Tongbai Xu, Dongsheng Li, Yuan He, Fuliang Zhang, Man Qiao, Yanhua Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12957-018-1362-1 |
Similar Items
-
Long‐term survival analysis of patients with non‐small cell lung cancer complicated with type 2 diabetes mellitus
by: Gaoxiang Wang, et al.
Published: (2020-05-01) -
Research Advance in Anti-lung Cancer Mechanism of Metformin
by: Gaoxiang WANG, et al.
Published: (2020-04-01) -
Effects of metformin treatment on radiotherapy efficacy in patients with cancer and diabetes: a systematic review and meta-analysis
by: Rao M, et al.
Published: (2018-10-01) -
Metformin and Biliary Tract Cancer in Patients With Type 2 Diabetes
by: Chin-Hsiao Tseng, et al.
Published: (2020-10-01) -
The effect of metformin and thiazolidinedione use on lung cancer in diabetics
by: Mazzone Peter J, et al.
Published: (2012-09-01)